“Thanks to the opportunities identified by the Bartels team, we have found an ideal partner for our company who recognizes the immense growth potential and is eager to realize it. The constructive and consistently reliable cooperation, along with the comprehensive support provided by the team throughout the entire process, were decisive for the successful conclusion of this complex transaction.”

Annette D. Pascoe & Jürgen F. Pascoe

ABOUT PASCOE

Pascoe, a leading family-owned business in Germany, has specialized in natural medicine for over three generations, spanning more than 125 years. With around 200 employees, the company has expanded its reach internationally, establishing branches in Canada, Austria, Slovakia, the Czech Republic, and the UK.
 

TRANSACTION BACKGROUND

For personal and family reasons, the Pascoe family has decided to step back from the company and has found a reliable partner in Dr. Bartels M&A Consulting to support it in this process.

With the takeover by the Spanish pharmaceutical company Uriach, the shareholders of Pascoe Naturmedizin have found an ideal partner to ensure the succession and future growth of the company.
 

SOLUTION

The owner family is handing over a very healthy company that can continue its growth trajectory, leveraging Uriach’s strong position in the European market. The transaction is seen as an ideal match, with Pascoe and Uriach complementing each other in product offerings, markets and distribution channels. The acquisition represents an important milestone in Uriach's international growth strategy.

The BMA team is very pleased to have contributed to this “perfect match” solution. BMA handled the complete project management, advising the shareholders throughout all stages of the process, from selecting and approaching potential investors to negotiating the LOI and finalizing contract discussions.

CLIENT

PASCOE Pharmazeutische Präparate GmbH

INDUSTRY

Pharma

TRANSACTION

Support of the shareholder in the process of selling 100% of the shares to Sidroga / Uriach Gruppe

SERVICES

M&A Sell-Side Advisory